Literature DB >> 2981428

Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus.

M A Gonda, F Wong-Staal, R C Gallo, J E Clements, O Narayan, R V Gilden.   

Abstract

A study was conducted of the genetic relation between human T-cell lymphotropic retroviruses and visna virus. The human T-cell lymphotropic viruses include those associated with T-cell malignancies (HTLV-I and HTLV-II) as well as the etiologic agent of the acquired immune deficiency syndrome (HTLV-III). Visna virus, a slowly replicating and pathogenic but nononcogenic retrovirus of sheep, is a member of the subfamily Lentivirinae. Results obtained by molecular hybridization and heteroduplex analysis indicated that a greater extent of nucleotide sequence homology exists between HTLV-III and visna virus than between HTLV-III and any of the other viruses. The homology observed under conditions of low stringency spanned the entire genome, but was strongest in the gag/pol region. The morphogenesis and fine structure of HTLV-III and visna virus also demonstrated striking similarities. The data provide strong evidence for a close taxonomic and thus evolutionary relation between HTLV-III and the Lentivirinae subfamily.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981428     DOI: 10.1126/science.2981428

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  88 in total

1.  HIV-2 antibody testing of blood donors with doubtful immunoblot results for HIV-1.

Authors:  J Knüver-Hopf; H Mohr; J Beyer; B Lambrecht; D Mix; H Rübsamen-Waigmann; H Schmitt
Journal:  Blut       Date:  1989-03

2.  Replication and cytopathic effects of ovine lentivirus strains in alveolar macrophages correlate with in vivo pathogenicity.

Authors:  M D Lairmore; G Y Akita; H I Russell; J C DeMartini
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins.

Authors:  M J Braun; J E Clements; M A Gonda
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Filtration sizes of human immunodeficiency virus type 1 and surrogate viruses used to test barrier materials.

Authors:  C D Lytle; S C Tondreau; W Truscott; A P Budacz; R K Kuester; L Venegas; R E Schmukler; W H Cyr
Journal:  Appl Environ Microbiol       Date:  1992-02       Impact factor: 4.792

5.  Purification and characterization of recombinant equine infectious anemia virus reverse transcriptase.

Authors:  S F Le Grice; M Panin; R C Kalayjian; N J Richter; G Keith; J L Darlix; S L Payne
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Important factors for testing barrier materials with surrogate viruses.

Authors:  C D Lytle; W Truscott; A P Budacz; L Venegas; L B Routson; W H Cyr
Journal:  Appl Environ Microbiol       Date:  1991-09       Impact factor: 4.792

7.  Genetic structure and function of an early transcript of visna virus.

Authors:  V Mazarin; I Gourdou; G Quérat; N Sauze; R Vigne
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  [AIDS and HTLV-III in West Germany: the status February 1985].

Authors:  R Hehlmann; V Erfle; G Hunsmann; R Kurth
Journal:  Klin Wochenschr       Date:  1985-05-02

9.  AIDS virus infection: prognosis and transmission.

Authors:  J Seale
Journal:  J R Soc Med       Date:  1985-08       Impact factor: 5.344

10.  Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.

Authors:  J M Orenstein; M S Meltzer; T Phipps; H E Gendelman
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.